This is a pre-recorded webinar that is accessible to watch on-demand at a time suitable for you. Access to the on-demand will include pre-recorded webinar/s, access to slides, speaker details and any available resources.
Upon purchase of your on-demand you will be sent a personalised link that is unique for you and will grant you access to your own on-demand page.
Overview
Diabetes mellitus in patients with cancer is very common. Diabetes remains one of the commonest comorbid conditions in patients with cancer and the co-existence of cancer and diabetes can have serious implications on cancer care. In this study day we discuss new research relating to the field and also provide updates in the clinical management of patients with both cancer and diabetes. This study day will be beneficial for all healthcare professionals who manage patients with either cancer or diabetes mellitus.
Intended Audience
What to expect
- Updates in the understanding of the relationship between diabetes and cancer.
- Overview of the management of patients with cancer and diabetes, Including specific case studies.
- An update about the impact of cancer treatments on blood glucose levels.
- An insight into the multidisciplinary care that patients with both cancer and diabetes require.
Low-to-Middle-Income Country (LMIC) course fees are offered at reduced rate. Countries eligible for LMIC reduced rate can be found here.
Countries listed under the headings "Low-Income Economies" and Lower-Middle-Income Economies" will be considered.
If you are currently domicile in an LMIC please email the-christie.educationevent@nhs.net attaching proof of employment from your current hospital/institute before booking and completing registration on Eventbrite
Please see our booking Terms and Conditions here
Click here to read our privacy policy: http://www.christie.nhs.uk/professionals/education/continuing-professional-development/study-days-and-conferences/school-of-oncology-events-privacy-policy/
Further information:
Email the-christie.educationevents@nhs.net or call +44 (0) 161 918 7409
